Suppr超能文献

在肝癌发生过程中,CCAAT/增强子结合蛋白α和β与谷胱甘肽S-转移酶P基因启动子中的沉默子元件相互作用。

CCAAT/enhancer-binding proteins alpha and beta interact with the silencer element in the promoter of glutathione S-transferase P gene during hepatocarcinogenesis.

作者信息

Osada S, Takano K, Nishihara T, Suzuki T, Muramatsu M, Imagawa M

机构信息

Department of Environmental Biochemistry, Faculty of Pharmaceutical Sciences, Osaka University, Japan.

出版信息

J Biol Chem. 1995 Dec 29;270(52):31288-93. doi: 10.1074/jbc.270.52.31288.

Abstract

We have previously identified a silencer in the glutathione S-transferase P (GST-P) gene which is strongly and specifically expressed during chemical hepatocarcinogenesis. At least three trans-acting factors bind to multiple cis-elements in the silencer. One of them, Silencer Factor-B (SF-B), is identical with CCAAT/enhancer-binding protein beta (C/EBP beta) and binds to GST-P Silencer 1 (GPS1). Many C/EBP beta binding sites are recognized by each of the C/EBP isoforms. Western blot analyses of C/EBP isoforms during chemical hepatocarcinogenesis revealed a decrease of C/EBP alpha expression. However, there was no change in C/EBP beta level. In the nuclear extracts from normal liver, C/EBP alpha was the dominant form that bound to GPS1, whereas both C/EBP alpha and C/EBP beta bound to GPS1 in the nuclear extracts from carcinogenic liver. Furthermore, transfection assays showed that C/EBP alpha not only repressed the GST-P promoter activity but also attenuated the transcriptional stimulation by C/EBP beta. These observations strongly suggest that the ratio of C/EBP alpha to C/EBP beta is one of the important factors for the GST-P silencer activity, and the decrease of this ratio during hepatocarcinogenesis reduces the silencer activity and, consequently, increases the GST-P expression.

摘要

我们之前在谷胱甘肽S-转移酶P(GST-P)基因中鉴定出一个沉默子,该基因在化学性肝癌发生过程中强烈且特异性表达。至少有三种反式作用因子与该沉默子中的多个顺式元件结合。其中之一,沉默子因子-B(SF-B),与CCAAT/增强子结合蛋白β(C/EBPβ)相同,并与GST-P沉默子1(GPS1)结合。许多C/EBPβ结合位点可被每种C/EBP异构体识别。对化学性肝癌发生过程中C/EBP异构体的蛋白质免疫印迹分析显示C/EBPα表达下降。然而,C/EBPβ水平没有变化。在正常肝脏的核提取物中,C/EBPα是与GPS1结合的主要形式,而在致癌肝脏的核提取物中,C/EBPα和C/EBPβ都与GPS1结合。此外,转染实验表明C/EBPα不仅抑制GST-P启动子活性,还减弱C/EBPβ的转录刺激作用。这些观察结果强烈表明C/EBPα与C/EBPβ的比例是GST-P沉默子活性的重要因素之一,肝癌发生过程中该比例的降低会降低沉默子活性,从而增加GST-P的表达。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验